Muutke küpsiste eelistusi

E-raamat: Primary and Stem Cells: Gene Transfer Technologies and Applications

  • Formaat: EPUB+DRM
  • Ilmumisaeg: 31-Oct-2011
  • Kirjastus: John Wiley & Sons Inc
  • Keel: eng
  • ISBN-13: 9781118147160
  • Formaat - EPUB+DRM
  • Hind: 135,79 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 31-Oct-2011
  • Kirjastus: John Wiley & Sons Inc
  • Keel: eng
  • ISBN-13: 9781118147160

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book describes basic cell engineering methods, emphasizing stem cell applications, and use of the genetically modified stem cells in cell therapy and drug discovery. Together, the chapters introduce and offer insights on new techniques for engineering of stem cells and the delivery of transgenes into stem cells via various viral and non-viral systems. The book offers a guide to the types of manipulations currently available to create genetically engineered stem cells that suit any investigator's purpose, whether it's basic science investigation, creation of disease models and screens, or cells for therapeutic applications.

Arvustused

This is an excellent resource on the new techniques for the engineering of stem cells and the delivery of transgenes into stem cells via various viral and nonviral systems. It provides comprehensive information on the concepts of cell engineering principles and their application in primary and stem cells.  Researchers, established stem cell scientists, and graduate students interested in this field will find this book very handy.  (Doodys, 17 August 2012)

 

 

 

Foreword vii
Michele Calos
Preface ix
Contributors xi
PART I CLONING AND GENE DELIVERY
1(48)
1 DNA Assembly Technologies Based on Homologous Recombination
3(16)
Billyana Tsvetanova
Lansha Peng
Xiquan Liang
Ke Li
Jian-Ping Yang
Tony Ho
Josh Shirley
Liewei Xu
Jason Potter
Wieslaw Kudlicki
Todd Peterson
Federico Katzen
2 Multigene Assembly for Construction of Synthetic Operons: Creation and Delivery of an Optimized All-IN-One Expression Construct for Generating Mouse iPS Cells
19(18)
Takefumi Sone
Yoko Takata
Hiroe Kishine
Taichi Andoh
Fumio Imamoto
Jonathan D. Chesnut
3 Strategies for the Delivery of Naked DNA
37(12)
Jennifer C. Moore
Ronald P. Hart
PART II NONINTEGRATING TECHNOLOGIES
49(86)
4 Episomal Vectors
51(34)
Junying Yu
5 Nonintegrating DNA Virus
85(18)
Chris Kemp
David Kuninger
6 Nonintegrating RNA Viruses
103(16)
Noemi Fusaki
7 Protein Delivery
119(16)
Xiao-Jian Han
Kazuhito Tomizawa
PART III INTEGRATING TECHNOLOGIES
135(92)
8 Sleeping Beauty Transposon-Mediated Stable Gene Delivery
137(26)
Andrew Wilber
Xianzheng Zhou
Xin Huang
Dan S. Kaufman
R. Scott McIvor
9 Integrating Viral Vectors for Gene Modifications
163(36)
Gemma L. Mendel
Brian Paszkiet
Rafal P. Witek
10 Bacteriophage Integrases for Site-Specific Integration
199(12)
Bhaskar Thyagarajan
11 Improving Gene Targeting Efficiency in Human Pluripotent Stem Cells
211(16)
Sangyoon Han
Anna McCann
Louise C. Laurent
Jeanne F. Loring
Ying Liu
PART IV APPLICATIONS
227(46)
12 Modified Stem Cells as Disease Models and in Toxicology Screening
229(22)
Catharina Ellerstrom
Peter Sartipy
Raimund Strehl
Johan Hyllner
13 Screening and Drug Discovery
251(22)
Elizabeth A. Davenport
Robert S. Ames
Index 273
UMA LAKSHMIPATHY is a principal investigator at Life Technologies. She has a PhD in life sciences, with academic and industry experience in molecular biology and stem cells. Dr. Lakshmipathy holds four patents and has authored more than forty publications. BHASKAR THYAGARAJAN is a program manager at Life Technologies. He has a PhD in pharmacology, with expertise in the areas of molecular biology, DNA recombination, gene and cell therapy, and protein purification. He holds one patent and has authored more than twenty publications.